Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened

T. Seeman, T. Šuláková, S. Stabouli

. 2023 ; 25 (9) : 231-242. [pub] 20230828

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016308
E-zdroje Online Plný text

NLK ProQuest Central od 2009-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1999-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2009-01-01 do Před 1 rokem

PURPOSE OF REVIEW: The goal is to review masked hypertension (MH) as a relatively new phenomenon when patients have normal office BP but elevated out-of-office BP. Firstly, it was described in children in 2004. It has received increased attention in the past decade. RECENT FINDINGS: The prevalence of MH in different pediatric populations differs widely between 0 and 60% based on the population studied, definition of MH, or method of out-of-office BP measurement. The highest prevalence of MH has been demonstrated in children with chronic kidney disease (CKD), obesity, diabetes, and after heart transplantation. In healthy children but with risk factors for hypertension such as prematurity, overweight/obesity, diabetes, chronic kidney disease, or positive family history of hypertension, the prevalence of MH is 9%. In healthy children without risk factors for hypertension, the prevalence of MH is very low ranging 0-3%. In healthy children, only patients with the following clinical conditions should be screened for MH: high-normal/elevated office BP, positive family history of hypertension, and those referred for suspected hypertension who have normal office BP in the secondary/tertiary center.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016308
003      
CZ-PrNML
005      
20231026110036.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11906-023-01260-6 $2 doi
035    __
$a (PubMed)37639176
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Seeman, Tomáš $u Department of Pediatrics, Charles University Prague, 2nd Medical Faculty, V Úvalu 84, 15006, Prague, Czech Republic. tomas.seeman@lfmotol.cuni.cz $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czech Republic. tomas.seeman@lfmotol.cuni.cz $1 https://orcid.org/0000000313713096
245    10
$a Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened / $c T. Seeman, T. Šuláková, S. Stabouli
520    9_
$a PURPOSE OF REVIEW: The goal is to review masked hypertension (MH) as a relatively new phenomenon when patients have normal office BP but elevated out-of-office BP. Firstly, it was described in children in 2004. It has received increased attention in the past decade. RECENT FINDINGS: The prevalence of MH in different pediatric populations differs widely between 0 and 60% based on the population studied, definition of MH, or method of out-of-office BP measurement. The highest prevalence of MH has been demonstrated in children with chronic kidney disease (CKD), obesity, diabetes, and after heart transplantation. In healthy children but with risk factors for hypertension such as prematurity, overweight/obesity, diabetes, chronic kidney disease, or positive family history of hypertension, the prevalence of MH is 9%. In healthy children without risk factors for hypertension, the prevalence of MH is very low ranging 0-3%. In healthy children, only patients with the following clinical conditions should be screened for MH: high-normal/elevated office BP, positive family history of hypertension, and those referred for suspected hypertension who have normal office BP in the secondary/tertiary center.
650    _2
$a lidé $7 D006801
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    12
$a maskovaná hypertenze $x diagnóza $x epidemiologie $7 D059468
650    12
$a hypertenze $x diagnóza $x epidemiologie $7 D006973
650    _2
$a rizikové faktory $7 D012307
650    _2
$a obezita $7 D009765
650    12
$a chronická renální insuficience $7 D051436
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šuláková, Terezie $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Pediatrics, Medical Faculty, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Stabouli, Stella $u 1st Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University Thessaloniki, Hippokratio Hospital, Thessaloniki, Greece
773    0_
$w MED00180209 $t Current hypertension reports $x 1534-3111 $g Roč. 25, č. 9 (2023), s. 231-242
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37639176 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110030 $b ABA008
999    __
$a ok $b bmc $g 2000056 $s 1202670
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 25 $c 9 $d 231-242 $e 20230828 $i 1534-3111 $m Current hypertension reports $n Curr Hypertens Rep $x MED00180209
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...